NEW YORK (GenomeWeb) – Transplant Genomics today announced a deal to exclusively license patent rights from The Scripps Research Institute and Northwestern University.

The Brookline, Mass.-based company will have access to intellectual property related to kidney and liver transplant diagnostics, such as immune status monitoring and optimization, and it intends to use the licensed technology develop and commercialize tests based on genomic biomarkers of transplant graft status. The tests would be used as part of a surveillance program to detect early signs of graft injury.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.